Search
Can Fite Biopharma Ltd
CANFAdd to Watchlist
4.700USD
+1.730+58.25%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
9.80MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Can Fite Biopharma Ltd is 7.00, ranking 112 out of 157 in the Pharmaceuticals industry. The average price target is 4.50, with a high of 11.00 and a low of 2.50.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
50.000
Target Price
+1583.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Can Fite Biopharma Ltd
CANF
1
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Can Fite Biopharma Ltd's price target?
Analysts forecast that Can Fite Biopharma Ltd's price target is USD 4.50, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.50.
What is the analyst rating for Can Fite Biopharma Ltd?
Based on the ratings of Can Fite Biopharma Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.